State Key Laboratory of Biotherapy and Cancer Center/Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.
Lung Cancer Center, Laboratory of Lung Cancer, West China Medical School, Sichuan University, Chengdu 610041, China.
J Med Chem. 2021 Mar 25;64(6):2851-2877. doi: 10.1021/acs.jmedchem.0c01640. Epub 2021 Mar 3.
Proteostasis is the process of regulating intracellular proteins to maintain the balance of the cell proteome, which is crucial for cancer cell survival. Several proteases located in the cytoplasm, mitochondria, lysosome, and extracellular environment have been identified as potential antitumor targets because of their involvement in proteostasis. Although the discovery of small-molecule inhibitors targeting proteases faces particular challenges, rapid advances in chemical biology and structural biology, and the new technology of drug discovery have facilitated the development of promising protease modulators. In this review, the protein structure and function of important tumor-related proteases and their inhibitors are presented. We also provide a prospective on advances and the outlook of new drug strategies that target these proteases.
蛋白质稳态是调节细胞内蛋白质以维持细胞蛋白质组平衡的过程,这对于癌细胞的存活至关重要。几种位于细胞质、线粒体、溶酶体和细胞外环境中的蛋白酶已被确定为潜在的抗肿瘤靶点,因为它们参与了蛋白质稳态的调节。尽管靶向蛋白酶的小分子抑制剂的发现面临着特殊的挑战,但化学生物学和结构生物学的快速发展以及药物发现的新技术促进了有前途的蛋白酶调节剂的开发。在这篇综述中,介绍了重要的肿瘤相关蛋白酶及其抑制剂的蛋白质结构和功能。我们还对靶向这些蛋白酶的新药策略的进展和前景进行了展望。